Does NVST Stock Still Deserve a Place in Your Portfolio?
Envista executes on growth priorities with new products, acquisitions and global expansion, but macro, tariff and currency headwinds remain in focus.
NVST - Envista Holdings Corp
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$28.20
DETAILS
HIGH:
$35.00
LOW:
$19.00
MEDIAN:
$29.00
CONSENSUS:
$28.20
UPSIDE:
5.58%
Stock News
Envista Schedules Second Quarter 2026 Earnings Call
BREA, Calif., July 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2026 on Wednesday, August 5, 2026.
NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?
Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
Envista Holdings Corporation's NVST ongoing international expansion is strengthening its presence across a broader range of markets, creating significant opportunities for long-term growth. Supported by the company's strategic priorities and growth-focused initiatives, it is well positioned to capitalize on emerging opportunities and deliver solid operational and financial performance in the upcoming quarters.
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Is NVST Attractive at 15.1x Forward Earnings?
Envista trades at 15.1x forward earnings; Q1 2026 profit surged, and a $24 target hinges on sustaining margins and sales gains.
NVST Stock Explained for 2026 Growth Drivers and Risks
Envista targets margin gains via its Business System while boosting R&D and buybacks, with a $24 6-12 month target vs $22.94.
Here's Why Envista (NVST) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista Holdings Corp (NVST) Shares Surge 3.1% -- What GF Score of 82 Tells Investors
On May 20, 2026, Envista Holdings Corp (NVST) shares rose 3.1% to a current price of $23.77. This move comes in the context of a 52-week range of $16.41 to $30.
Why Envista (NVST) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets.
Envista Q1 Earnings Call Highlights
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
Envista (NVST) International Revenue Performance Explored
Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Why Envista (NVST) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the company's own cost reduction efforts. The company's high-teens EPS growth guidance for the full year is well-supported by new product launches and synergies relating to its latest M&A.
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.24 per share a year ago.
Envista Reports First Quarter 2026 Results
BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST)
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Envista (NYSE: NVST - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings This table compares Stagezero Life
Price Targets
Envista initiated with a Market Perform at BMO Capital
$27.00
(was $25.74)
Vik Chopra
·
BMO Capital
Envista price target lowered to $32 from $34 at Barclays
$32.00
(was $24.06)
Barclays
Envista price target raised to $33 from $30 at Evercore ISI
$33.00
(was $25.52)
Elizabeth Anderson
·
Evercore ISI
Envista price target raised to $31 from $30 at Baird
$31.00
(was $27.06)
Jeff Johnson
·
Robert W. Baird
Envista price target lowered to $30 from $32 at Evercore ISI
$30.00
(was $26.66)
Evercore ISI
Envista price target raised to $30 from $27 at Baird
$30.00
(was $28.36)
Robert W. Baird
Envista price target raised to $19 from $18 at Morgan Stanley
$19.00
(was $28.09)
Morgan Stanley
Envista price target raised to $32 from $26 at Evercore ISI
$32.00
(was $28.43)
Elizabeth Anderson
·
Evercore ISI
Envista price target raised to $31 from $27 at Stifel
$31.00
(was $24.71)
Stifel Nicolaus
Envista price target raised to $25 from $21 at Piper Sandler
$25.00
(was $24.71)
Jason Bednar
·
Piper Sandler
Leerink upgrades Envista to Outperform on improved growth, execution
$35.00
(was $24.71)
Leerink Partners
Envista price target raised to $27 from $25 at Stifel
$27.00
(was $23.27)
Jonathan Block
·
Stifel Nicolaus
Envista price target raised to $25 from $22 at UBS
$25.00
(was $23.26)
Kevin Caliendo
·
UBS
Envista price target raised to $21 from $19 at Piper Sandler
$21.00
(was $23.39)
Piper Sandler
Envista upgraded to Neutral from Underperform at Mizuho
$24.00
(was $25.24)
Steven Valiquette
·
Mizuho Securities
Envista initiated with an Overweight at Barclays
$24.00
(was $20.01)
Barclays
Envista Holdings Corp. (NVST) PT Raised to $19 at Mizuho
$19.00
(was $20.35)
Steven Valiquette
·
Mizuho Securities
Envista price target raised to $27 from $25 at Baird
$27.00
(was $20.14)
Robert W. Baird
Stifel Reiterates Buy Rating on Envista Holdings Corp. (NVST)
$25.00
(was $20.37)
Jonathan Block
·
Stifel Nicolaus
Envista added to 'Tactical Outperform' list at Evercore ISI
$25.00
(was $20.40)
Evercore ISI